In-hospital hyperglicemia: Impact on overall morbidity and mortality in patients undergoing cardiovascular surgery

Abstract

In hospital hyperglycemia is defined as a glucose value >140 mg/dL, this value can be present in individuals with already known Diabetes and present in patients without previous diagnosis and in patients who present hyperglycemia during hospitalization secondary to stress phenomena, the American Diabetes Association (ADA), the Endocrine Society, the American Heart Association (AHA), the American Association of Diabetes Educators (AADE) and the European Society of Endocrinology, it is recommended to maintain glycemia in hospitalization in the range between 140 mg / dL and 180 mg / dL. The main objective of this study was to determine the effect of in-hospital hyperglycemia on morbidity and mortality in patients undergoing cardiovascular surgery at the Centro Médico Docente la Trinidad, in the period from January 2018 to August 2020, to achieve this a Retrospective analytical observational study, where the data of 59 patients with diagnoses of intrahospital hyperglycemia undergoing cardiovascular surgery was collected with a total sample of 37 patients, where it was observed that there were greater medical complications than surgical ones, and of these the most frequent were acute kidney injury , atrial fibrillation, and acid-base disorder, likewise, the variables most related to medical complications were: patients with glycemia at admission> 180 mg / dl, wide glycemic excursions, glycemia at discharge ≥140mg / dl, Patients Undergoing Cardiac Surgery cardiovascular and that glycemic variability was the main risk factor to consider to determine risk of morbidity and mortality